A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients

Clinical trial NCT02640807 · COMPLETED

Trial details

NCT number: NCT02640807
Sponsor: Revimmune
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Sepsis With Septic Shock

Start date: 2016-01-01
Primary completion: 2018-08-27
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.